Consolidated Statements Of Cash Flow (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Operating Activities:
Net income	$ 45,720	$ 53,794
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization	33,429	25,283
Amortization of senior note offering and credit facility costs	1,024	931
Amortization of share-based awards	4,247	3,758
Deferred income taxes	6,371	11,883
Changes in assets and liabilities, net of acquisitions:
Increase in accounts receivable	(42,867)	(8,915)
Increase in inventories	(34,763)	(27,323)
Decrease (increase) in prepaid expenses and other assets	2,936	(1,944)
Increase in accounts payable	8,200	19,023
Decrease in other payables, accrued expenses and other liabilities	(33,263)	(26,075)
Other	118	(84)
Net cash (used in) provided by operating activities	(8,848)	50,331
Investing Activities:
Additions to property and equipment	(30,388)	(16,785)
Acquisition of intangibles and other assets	(8,068)	(43,900)
Net cash used in investing activities	(38,456)	(60,685)
Financing Activities:
Proceeds from short-term debt	27,050
Repurchase of common stock	(12,515)
Proceeds from the exercise of stock options	4,693	5,258
Proceeds from the issuance of common stock under the employee stock purchase plan	1,057	958
Payments of contingent consideration related to acquisition	(4,960)
Excess tax benefit from share-based awards	5,085	4,703
Net cash provided by financing activities	20,410	10,919
Effect of exchange rate changes on cash and cash equivalents	(744)	(1,208)
Net decrease in cash and cash equivalents	(27,638)	(643)
Cash and cash equivalents at beginning of period	59,080	58,850
Cash and cash equivalents at end of period	31,442	58,207
Supplemental Disclosure of Non-Cash Information:
Additions to property and equipment not paid for (not included above)	$ 353	$ 384